First Patients Treated With Experimental Therapy Remained in Remission 10 Years Later: Study

Researchers of a new study say that two patients with leukemia continued to be in remission a decade after they were first infused with the experimental CAR T-cell therapy that turned their immune cells into cancer-killing cells. In 2010, Doug Olson and Bill Ludwig, participated in an experimental phase 1 clinical trial of the immunotherapy, after their cancer had mutated and no longer responded to the standard treatments. Both were battling chronic lymphocytic leukemia (CLL), a type of blood an...